James Rolke - 08 Jan 2026 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Executive Officer, Director
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke
Issuer symbol
REVB
Transactions as of
08 Jan 2026
Net transactions value
+$479,546
Form type
4
Filing time
12 Jan 2026, 17:21:07 UTC
Previous filing
31 Oct 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolke James Chief Executive Officer, Director C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO /s/ J.P. Galda, as attorney-in-fact for James Rolke 12 Jan 2026 0001693858

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $479,546 +532,829 +133% $0.9000 933,489 08 Jan 2026 Direct F1
holding REVB Common Stock 400,660 08 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.